The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|16|2|80-88

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.16, Iss.2, 2016-09, pp. : 80-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy for Primary Immunodeficiency Diseases: Recent Progress and Misgivings

By  

Current Pharmaceutical Design, Vol. 12, Iss. 5, 2006-02 ,pp. : 549-556

Bentham Science Publishers

Access to resources Recommend Favorite

Patients with common variable immunodeficiency (CVID) requiring IV immunoglobulin (IVIG) therapy have poorer health-related (HR) QOL than individuals with other chronic diseases

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 461, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy

By Ahmed A Razzaque  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. : 1019-1032

Informa Healthcare

Access to resources Recommend Favorite

Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-01 ,pp. : 4570-4582

Bentham Science Publishers

Access to resources Recommend Favorite

Intravenous Immunoglobulin Replacement Therapy in the Treatment of Patients with Common Variable Immunodeficiency Disease: An Open-Label Prospective Study

By Kasztalska Karolina  

Clinical Drug Investigation, Vol. 31, Iss. 5, 2011-05 ,pp. : 299-307

Adis International

Access to resources Recommend Favorite